Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001084669 | SCV000287406 | likely benign | Hypertrophic cardiomyopathy 14 | 2024-11-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000251514 | SCV000319927 | likely benign | Cardiovascular phenotype | 2023-10-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000443494 | SCV000535687 | uncertain significance | not provided | 2024-02-26 | criteria provided, single submitter | clinical testing | Identified in patients with HCM and cardiac conduction system disease (CCSD) (PMID: 18258667, 31977013); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 18258667, 35621855, 29875424, 31977013) |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV000623582 | SCV000740619 | uncertain significance | Primary familial hypertrophic cardiomyopathy | 2017-02-11 | criteria provided, single submitter | clinical testing |